Cancer Platform Offers Targeted Treatment
A platform that aims to change outcomes for dogs diagnosed with cancer recently received $10 million in new funding that will allow the company to grow and give more dogs access to precision treatment. FidoCure uses genetic testing to identify what genetic mutation might be behind a dog’s cancer. Once testing is complete, FidoCure offers …
